EUVIMEDEUVIMED entdecken
Crossref

Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia

Olga H Hernández-Ortiz iD, Andrés Felipe Naranjo, Juan José Vélez Cadavid, Gisela de la Rosa Echavez, Sara Moreno-Bedoya, Bladimir Alejandro Gil Valencia, Jorge E Sará Ochoa, Francisco Molina Saldarriaga, A Melissa Moreno, Laura S Perez-Restrepo, Jaime Usuga, Jorge E Osorio und 2 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70508 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Olga H Hernández-Ortiz und 13 weiteren Autor:innen. Beteiligte Einrichtung: GHI One Health Colombia and One Health Genomic Laboratory, Universidad Nacional de Colombia, Medellín, Colombia. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: This study was supported by Grupo SURA, Grupo ISA, Minera de Cobre Quebradona - Anglogold, Mineros Aluvial S.A, Corbeta, Sumicol Corona, Fundación Fraternidad….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To effectively curb coronavirus disease 2019 (COVID‐19), it is essential to understand the risk factors for breakthrough acute infections of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) despite vaccination. We conducted a case‐control study to assess risk factors for acute SARS‐CoV‐2 infections requiring hospitalization in vaccinated individuals. The study included 50 vaccinated patients who experienced breakthrough infections requiring hospitalization (inpatient cohort) and 250 control participants from the outpatient cohort of the “Genomic Surveillance and Immune Response Monitoring for COVID‐19 in the Metropolitan Area of the Aburrá Valley, Medellín‐Colombia”. Demographic characteristics, vaccination status, and immune responses were compared between cases and controls using multivariate logistic regression. Advanced age (≥ 65 years), male sex, high‐risk comorbidities, and immunosuppression were associated with an increased risk of breakthrough SARS‐CoV‐2 infections despite prior vaccination. In contrast, receipt of a booster dose and the presence of neutralizing antibodies were linked to a reduced risk of such infections. This study identifies key risk and protective factors associated with breakthrough SARS‐CoV‐2 infections. Derived from a high–middle‐income setting, these real‐world findings provide valuable insights to guide targeted vaccination strategies for vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesHumansMaleFemaleCase-Control StudiesColombiaAgedRisk FactorsMiddle AgedProspective StudiesVaccinationAdultAntibodies, NeutralizingHospitalizationAntibodies, ViralAged, 80 and overBreakthrough Infections

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2breakthrough infectionsvaccination

Substanzen

COVID-19 VaccinesAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • GHI One Health Colombia and One Health Genomic Laboratory, Universidad Nacional de Colombia, Medellín, Colombia.
  • Clínica Medellín-Grupo Quirónsalud, Medellín, Colombia.
  • Universidad de Antioquia, Medellín, Colombia.
  • Hospital General de Medellín y Clínica las Américas-Auna, Medellín, Colombia.
  • Hospital Pablo Tobón Uribe, Medellín, Colombia.
  • Clínica CES, Residente Anestesiología, Universidad CES, Medellín, Colombia.

ORCID-Profile: Olga H Hernández-Ortiz

Förderung

  • This study was supported by Grupo SURA, Grupo ISA, Minera de Cobre Quebradona - Anglogold, Mineros Aluvial S.A, Corbeta, Sumicol Corona, Fundación Fraternidad…

Zitieren

APA

Hernández-Ortiz, O. H., Naranjo, A. F., Cadavid, J. J. V., Echavez, G. R., Moreno-Bedoya, S., Valencia, B. A. G., Ochoa, J. E. S., Saldarriaga, F. M., Moreno, A. M., Perez-Restrepo, L. S., Usuga, J., Osorio, J. E., Hernández-Ortiz, J. P., & Jaimes, F. (2025). Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia. Journal of Medical Virology. https://doi.org/10.1002/jmv.70508

Vancouver

Hernández-Ortiz OH, Naranjo AF, Cadavid JJV, Echavez GR, Moreno-Bedoya S, Valencia BAG, et al. Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia. Journal of Medical Virology. 2025. doi:10.1002/jmv.70508

BibTeX
@article{HernndezOrtiz2025,
  author = {Hernández-Ortiz, Olga H and Naranjo, Andrés Felipe and Cadavid, Juan José Vélez and Echavez, Gisela de la Rosa and Moreno-Bedoya, Sara and Valencia, Bladimir Alejandro Gil and Ochoa, Jorge E Sará and Saldarriaga, Francisco Molina and Moreno, A Melissa and Perez-Restrepo, Laura S and Usuga, Jaime and Osorio, Jorge E and Hernández-Ortiz, Juan Pablo and Jaimes, Fabian},
  title = {Risk Factors for Breakthrough Acute SARS‐CoV‐2 Infections in Fully Vaccinated Individuals: A Case‐Control Study Nested in a Prospective Cohort in Medelln, Colombia},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70508}
}
Kostenlos starten →